drugset / Trial / NCT00407225
Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this phase 2 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of postoperative inflammation.
Timeline
- Start
- 1999-12
- Primary completion
- —
- Completion
- 2000-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Difluprednate | Small molecule | 0.002 % | — |
| Subject | Difluprednate | Small molecule | 0.05 % | — |
Indications
No indication recorded.